These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35290681)

  • 21. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
    Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
    Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
    Feng X; Su H; Xie J
    J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
    Chatterjee M; Neema S; Rajput GR
    Indian J Dermatol Venereol Leprol; 2021; 88(1):51-58. PubMed ID: 34379946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review.
    Jutley GS; Rajaratnam R; Halpern J; Salim A; Emmett C
    J Am Acad Dermatol; 2014 Feb; 70(2):369-73. PubMed ID: 24438951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical and Systemic Therapies in Melasma: A Systematic Review.
    Sarkar R; Handog EB; Das A; Bansal A; Macarayo MJ; Keshavmurthy V; Narayan V; Jagadeesan S; Pipo E; Ibaviosa GM; Podder I; Bansal S
    Indian Dermatol Online J; 2023; 14(6):769-781. PubMed ID: 38099013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for mycosis fungoides.
    Weberschock T; Strametz R; Lorenz M; Röllig C; Bunch C; Bauer A; Schmitt J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008946. PubMed ID: 22972128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
    Ferreira Cestari T; Hassun K; Sittart A; de Lourdes Viegas M
    J Cosmet Dermatol; 2007 Mar; 6(1):36-9. PubMed ID: 17348994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of retinoic acid in the treatment of melasma.
    Pathak MA; Fitzpatrick TB; Kraus EW
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
    Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
    Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical Treatments for Melasma and Their Mechanism of Action.
    González-Molina V; Martí-Pineda A; González N
    J Clin Aesthet Dermatol; 2022 May; 15(5):19-28. PubMed ID: 35642229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical metformin in the treatment of melasma: A preliminary clinical trial.
    Banavase Channakeshavaiah R; Andanooru Chandrappa NK
    J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
    Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
    Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.